Key Takeaways:
- JIANGXI BIO opened at HK$7.4, down 33.9% from its HK$11.2 IPO price.
- The stock recovered to close midday at HK$10.1 on volume of 19.17 million shares.
- Turnover reached HK$191.19 million in the first half of trading.
Key Takeaways:

JIANGXI BIO (06915.HK) closed its first trading session midday at HK$10.1, down 9.8% from its HK$11.2 listing price.
The stock opened at HK$7.4, a 33.9% decline from the IPO price, before recovering to a session high of HK$10.75. The low touched HK$7.3. Volume reached 19.17 million shares, with turnover of HK$191.19 million.
The weak debut signals tepid demand for new listings on the Hong Kong Main Board amid cautious investor sentiment. The stock's recovery from its opening low suggests some buying interest emerged at lower levels, but the midday close still 9.8% below the IPO price leaves early investors underwater.
The pricing gives JIANGXI BIO an enterprise value that will be tested by institutional demand in the coming sessions. Investors will watch whether the stock can hold above its intraday low of HK$7.3 in afternoon trading.
This article is for informational purposes only and does not constitute investment advice.